文献速递哮喘

产前烟草暴露与儿童期哮喘及过敏结局风险

Prenatal tobacco exposure and risk of asthma and allergy outcomes in childhood.
PubMed 文献 · Eur Respir J · 2022-02-17

基于COPSAC2000出生队列411名儿童随访至7岁,产前烟草暴露增加哮喘诊断(aHR 2.05)、急性加重(aHR 3.76)和下呼吸道感染次数(aIRR 1.87),并降低肺功能指标、增加支气管高反应性,但与任何过敏相关终点无关;哮喘效应依赖17q12-21基因型,仅见于无风险等位基因儿童。

要点

  • 产前烟草暴露增加儿童哮喘诊断和急性加重风险,且与肺功能下降及支气管高反应性相关。
  • 产前烟草暴露与过敏相关终点(致敏、过敏性鼻炎、FeNO、血嗜酸性粒细胞等)无关。
  • 哮喘效应依赖17q12-21基因型,仅见于无风险等位基因的儿童。

核心结论

  • 产前烟草暴露与儿童期哮喘、急性加重、肺功能下降及支气管高反应性相关,但与过敏相关结局无关,提示宫内烟草暴露主要导致肺发育/结构不良效应而非过敏和2型炎症易感性。

研究设计与样本

  • 基于COPSAC2000出生队列的411名儿童,随访至7岁,产前烟草暴露由母亲妊娠晚期吸烟(是/否)确定,以rs7216389代表17q12-21位点。

主要发现

  • 产前烟草暴露增加哮喘风险(aHR 2.05,95%CI 1.13-3.73;p=0.02)和急性加重风险(aHR 3.76,95%CI 2.05-6.91;p<0.001)。
  • 产前烟草暴露增加下呼吸道感染次数(aIRR 1.87,95%CI 1.34-2.55;p<0.001)。
  • 产前烟草暴露与FEV1降低(aMD -0.07 L,95%CI -0.13至-0.005 L;p=0.03)和MMEF降低(aMD -0.19 L·s-1,95%CI -0.34至-0.04 L·s-1;p=0.01)相关。
  • 产前烟草暴露增加对乙酰甲胆碱的支气管高反应性(PD20 aGMR 0.55,95%CI 0.31-0.96;p=0.04)。
  • 产前烟草暴露与任何过敏相关终点均无关联,且哮喘效应仅见于无17q12-21风险等位基因的儿童。

临床怎么用

  • 临床评估儿童哮喘风险时应询问母亲妊娠期吸烟史,并将其视为独立于过敏素质的哮喘及肺功能不良相关因素。
  • 对产前烟草暴露儿童应关注哮喘急性加重和下呼吸道感染风险,并考虑早期肺功能监测。

局限性

  • 样本量较小(411名儿童),随访至7岁,结论外推需谨慎。
  • 产前烟草暴露仅基于母亲妊娠晚期吸烟是/否,未量化暴露剂量。
  • 过敏相关终点可能受随访时间和检测方法限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Harmful effects of prenatal tobacco exposure and possible interaction with 17q12-21 genetic variants have been shown for some asthma outcomes in childhood, whereas findings related to allergy outcomes are more inconsistent. This study aimed to examine the effect of prenatal tobacco exposure and relation to 17q12-21 genotype on a wide array of asthma and allergy-related outcomes in early childhood. METHODS: Prenatal tobacco exposure was determined by maternal smoking during the third trimester (yes/no) in 411 children from the phenotyped Copenhagen Prospective Studies on Asthma in Childhood 2000 (COPSAC2000) birth cohort with clinical follow-up to age 7 years. The rs7216389 single nucleotide polymorphism was used as main representative of the 17q12-21 locus. Asthma end-points included asthma diagnosis, exacerbations, episodes with troublesome lung symptoms and lower respiratory tract infections, spirometry, plethysmography, bronchial responsiveness to methacholine, exercise and cold dry air. Allergy-related endpoints included aeroallergen sensitisation, allergic rhinitis, fractional exhaled nitric oxide, blood eosinophil count and urine eosinophil protein X levels. Statistical analyses were done using Cox regression, linear regression, logistic regression and quasi-Poisson regression. RESULTS: Prenatal tobacco exposure increased the risk of asthma (adjusted hazard ratio (aHR) 2.05, 95% CI 1.13-3.73; p=0.02), exacerbations (aHR 3.76, 95% CI 2.05-6.91; p<0.001), number of LRTIs (adjusted incidence rate ratio 1.87, 95% CI 1.34-2.55; p<0.001), and was associated with decreased spirometry indices (forced expiratory volume in 1 s (FEV1) adjusted mean difference (aMD) -0.07 L, 95% CI -0.13- -0.005 L, p=0.03; maximal mid-expiratory flow aMD -0.19 L·s-1, -0.34- -0.04 L·s-1, p=0.01) and increased bronchial responsiveness to methacholine (provocative dose of methacholine causing a 20% drop in FEV1 adjusted geometric mean ratio 0.55, 95% CI 0.31-0.96; p=0.04). In contrast, there was no association with any allergy-related end-points. The effect on asthma depended on 17q12-21 genotype with an increased risk only among children without risk alleles. CONCLUSION: Prenatal tobacco exposure was associated with asthma dependent on 17q12-21 genotype and with exacerbations, lung function and bronchial responsiveness, but not with any allergy-related outcomes. This suggests that tobacco exposure in utero leads to adverse lung developmental/structural effects rather than susceptibility to develop allergy and type 2 inflammation.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Sunde RB, Thorsen J, Pedersen CT, et al. Prenatal tobacco exposure and risk of asthma and allergy outcomes in childhood. Eur Respir J. 2022. PMID: 34244319. doi:10.1183/13993003.00453-2021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。